Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geert W Haasnoot

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|October 21, 2018
The long and winding road towards epitope matching in clinical transplantationCynthia S M Kramer, Moshe Israeli, Arend Mulder, et al.
HLA|August 22, 2024
Introduction of the donor centre virtual crossmatch in EurotransplantSebastiaan Heidt, Cynthia S M Kramer, Geert W Haasnoot, et al.
Journal of Reproductive Immunology|February 25, 2018
Maternal and child human leukocyte antigens in congenital cytomegalovirus infectionRoberta Rovito, Frans H J Claas, Geert W Haasnoot, et al.
Human Immunology|February 18, 2014
Uncomplicated oocyte donation pregnancies are associated with a higher incidence of human leukocyte antigen alloantibodiesLisa E E L O Lashley, Marie-Louise P van der Hoorn, Geert W Haasnoot, et al.
Transplant Immunology|June 20, 2012
The risk of cancer is not increased in patients with multiple kidney transplantationsHermina C Wisgerhof, Ron Wolterbeek, Geert W Haasnoot, et al.
Frontiers in Immunology|January 23, 2018
Congenital Cytomegalovirus Infection: Maternal-Child HLA-C, HLA-E, and HLA-G Affect Clinical OutcomeRoberta Rovito, Frans H J Claas, Geert W Haasnoot, et al.
Transplantation|May 15, 2007
Simpler and equitable allocation of kidneys from postmortem donors primarily based on full HLA-DR compatibilityIlias I N Doxiadis, Johan W de Fijter, Marko J K Mallat, et al.
Transplantation|April 23, 2010
Subsequent squamous- and basal-cell carcinomas in kidney-transplant recipients after the first skin cancer: cumulative incidence and risk factorsHermina C Wisgerhof, Jeroen R J Edelbroek, Johan W de Fijter, et al.
Transfusion|February 23, 2020
Ensuring HLA-matched platelet support requires an ethnic diverse donor populationAukje L Kreuger, Geert W Haasnoot, Judith A E Somers, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2021
Two Human Monoclonal HLA-Reactive Antibodies Cross-React with Mamu-B*008, a Rhesus Macaque MHC Allotype Associated with Control of Simian Immunodeficiency Virus ReplicationNatasja G de Groot, Corrine M C Heijmans, Suzanne Bezstarosti, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Transplant International : Official Journal of the European Society for Organ Transplantation|October 21, 2018
The long and winding road towards epitope matching in clinical transplantationCynthia S M Kramer, Moshe Israeli, Arend Mulder, et al.
HLA|August 22, 2024
Introduction of the donor centre virtual crossmatch in EurotransplantSebastiaan Heidt, Cynthia S M Kramer, Geert W Haasnoot, et al.
Journal of Reproductive Immunology|February 25, 2018
Maternal and child human leukocyte antigens in congenital cytomegalovirus infectionRoberta Rovito, Frans H J Claas, Geert W Haasnoot, et al.
Human Immunology|February 18, 2014
Uncomplicated oocyte donation pregnancies are associated with a higher incidence of human leukocyte antigen alloantibodiesLisa E E L O Lashley, Marie-Louise P van der Hoorn, Geert W Haasnoot, et al.
Transplant Immunology|June 20, 2012
The risk of cancer is not increased in patients with multiple kidney transplantationsHermina C Wisgerhof, Ron Wolterbeek, Geert W Haasnoot, et al.
Frontiers in Immunology|January 23, 2018
Congenital Cytomegalovirus Infection: Maternal-Child HLA-C, HLA-E, and HLA-G Affect Clinical OutcomeRoberta Rovito, Frans H J Claas, Geert W Haasnoot, et al.
Transplantation|May 15, 2007
Simpler and equitable allocation of kidneys from postmortem donors primarily based on full HLA-DR compatibilityIlias I N Doxiadis, Johan W de Fijter, Marko J K Mallat, et al.
Transplantation|April 23, 2010
Subsequent squamous- and basal-cell carcinomas in kidney-transplant recipients after the first skin cancer: cumulative incidence and risk factorsHermina C Wisgerhof, Jeroen R J Edelbroek, Johan W de Fijter, et al.
Transfusion|February 23, 2020
Ensuring HLA-matched platelet support requires an ethnic diverse donor populationAukje L Kreuger, Geert W Haasnoot, Judith A E Somers, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2021
Two Human Monoclonal HLA-Reactive Antibodies Cross-React with Mamu-B*008, a Rhesus Macaque MHC Allotype Associated with Control of Simian Immunodeficiency Virus ReplicationNatasja G de Groot, Corrine M C Heijmans, Suzanne Bezstarosti, et al.
Pageof 8